SI
ANAB icon

Sofinnova Investments’s AnaptysBio ANAB Stock Holding History

Sofinnova Investments’s Portfolio ANAB Stock Details ANAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$33.3M Buy
493,536
+245,283
+99% +$14.9M 1.72% 21
2026
Q1 		$13.8M Sell
248,253
-39,437
-14% -$2.12M 0.52% 43
2025
Q4 		$13.9M Buy
287,690
+33,422
+13% +$1.3M 0.6% 39
2025
Q3 		$7.79M Sell
254,268
-778,094
-75% -$17.9M 0.43% 48
2025
Q2 		$22.9M Sell
1,032,362
-127,671
-11% -$2.67M 1.4% 22
2025
Q1 		$21.6M Buy
1,160,033
+1,027,106
+773% +$17.1M 1.41% 25
2024
Q4 		$1.76M Buy
+132,927
New +$3.22M 0.13% 49
2019
Q2 		– Sell
-97,948
Closed -$7.16M – 71
2019
Q1 		$7.16M Buy
97,948
+72,928
+291% +$5.03M 0.69% 28
2018
Q4 		$1.59M Sell
25,020
-44,595
-64% -$3.32M 0.2% 54
2018
Q3 		$6.95M Buy
+69,615
New +$5.78M 0.62% 30

Other funds holding ANAB

EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return
S
Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return

Sofinnova Investments's ANAB Position: Q2 2026 in Review

Sofinnova Investments increased its AnaptysBio (ANAB) stake by 99% in Q2 2026, buying an estimated $14.9M and bringing the position to 493,536 shares worth $33.3M. The position accounts for 1.72% of the portfolio, ranked #21.

Sofinnova Investments first reported a position in ANAB in Q3 2018 and has held it in 10 quarters since. 213 funds tracked by Wall St. Rank hold ANAB as of Q2 2026.

  • Sofinnova Investments held 493,536 shares of AnaptysBio worth $33.3M as of Q2 2026.
  • Sofinnova Investments bought 245,283 AnaptysBio shares in Q2 2026, an estimated $14.9M.
  • AnaptysBio made up 1.72% of Sofinnova Investments's portfolio in Q2 2026, its #21 holding.
  • Sofinnova Investments first reported a position in AnaptysBio in Q3 2018 and has held it in 10 quarters since.
  • 213 funds tracked by Wall St. Rank held AnaptysBio as of Q2 2026.

Based on Sofinnova Investments's 13F filing for Q2 2026, filed 14 Aug 2026.